UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

Nature communications, 2018-11, Vol.9 (1), p.4664-5, Article 4664

2018

Volltextzugriff (PDF)

Molecular sputum analysis for the diagnosis of lung cancer

British journal of cancer, 2013-08, Vol.109 (3), p.530-537

2013

Volltextzugriff (PDF)

Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools

Annals of oncology, 2017-11, Vol.28 (11), p.2725-2732

2017

Volltextzugriff (PDF)

Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment

British journal of cancer, 2016-12, Vol.115 (12), p.1504-1512

2016

Volltextzugriff (PDF)

ES25.04 Multiple Pulmonary Lesions: Metastasis vs Multiple Primaries, From Martini's Criteria to Molecular Profiling

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S91-S92

Thunnissen, E.

2021

Volltextzugriff (PDF)

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach

British journal of cancer, 2015-03, Vol.112 (6), p.1105-1113

2015

Volltextzugriff (PDF)

Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression

PloS one, 2017-08, Vol.12 (8), p.e0182885-e0182885

2017

Volltextzugriff (PDF)

P06.02 Incorporating Surgical Collapse in the Pathological Assessment of Resected Adenocarcinoma in situ of the Lung. A Proof of Principle Study

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S985-S985

2021

Volltextzugriff (PDF)

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing

British journal of cancer, 2014-07, Vol.111 (2), p.413-420

2014

Volltextzugriff (PDF)

A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation

Annals of oncology, 2012-12, Vol.23 (12), p.3188-3189

2012

Volltextzugriff (PDF)

Granular cell tumor of the oral cavity; a case series including a case of metachronous occurrence in the tongue and the lung

Medicina oral, patología oral y cirugía bucal, 2015-01, Vol.20 (1), p.e30-e33

2015

Volltextzugriff (PDF)

MTE 02.01 Appropriate and Optimized Handling of Surgically Resected Specimens

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1633-S1634

Thunnissen, E.

2017

Volltextzugriff (PDF)

Inter-rater reliability of programmed death ligand 1 (PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii49-viii49

2018

Volltextzugriff (PDF)

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

The New England journal of medicine, 2020-02, Vol.382 (6), p.503-513

2020

Volltextzugriff (PDF)

OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S325-S325

2018

Volltextzugriff (PDF)

Lung Cysts as Indicator for Birt–Hogg–Dubé Syndrome

Lung, 2014-02, Vol.192 (1), p.215-216

2014

Volltextzugriff (PDF)

MA12.08 Pagetoid Growth of Squamous Cell Carcinoma with a Subsolid Component

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S87-S88

2022

Volltextzugriff (PDF)

Guidance for laboratories performing molecular pathology for cancer patients

Journal of clinical pathology, 2014-11, Vol.67 (11), p.923-931

2014

Volltextzugriff (PDF)

Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?

Journal of thoracic oncology, 2015-07, Vol.10 (7), p.985-989

2015

Volltextzugriff (PDF)

EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations

Virchows Archiv : an international journal of pathology, 2012-09, Vol.461 (3), p.245-257

2012

Volltextzugriff (PDF)

FP14.03 Diagnostic Accuracy in Central Pulmonary Carcinoid tumors is Dependent of Biopsy Size

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S971-S971

2021

Volltextzugriff (PDF)

Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors

Strahlentherapie und Onkologie, 2014-02, Vol.190 (2), p.204-209

2014

Volltextzugriff (PDF)

Association of tumor and stroma PD-1, PD-L1, CD3, CD4 and CD8 expression with response to nivolumab treatment in NSCLC patients

Annals of oncology, 2017-09, Vol.28, p.v29-v29

2017

Volltextzugriff (PDF)

P66.04 A Multimodal Biomarker Predicts Dissemination of Bronchial Carcinoid

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1193-S1193

2021

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Englisch
(198)
Niederländisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

Molecular sputum analysis for the diagnosis of lung cancer

Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools

Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment

ES25.04 Multiple Pulmonary Lesions: Metastasis vs Multiple Primaries, From Martini's Criteria to Molecular Profiling

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach

Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression

P06.02 Incorporating Surgical Collapse in the Pathological Assessment of Resected Adenocarcinoma in situ of the Lung. A Proof of Principle Study

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing

A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation

Granular cell tumor of the oral cavity; a case series including a case of metachronous occurrence in the tongue and the lung

MTE 02.01 Appropriate and Optimized Handling of Surgically Resected Specimens

Inter-rater reliability of programmed death ligand 1 (PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC)

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

Lung Cysts as Indicator for Birt–Hogg–Dubé Syndrome

MA12.08 Pagetoid Growth of Squamous Cell Carcinoma with a Subsolid Component

Guidance for laboratories performing molecular pathology for cancer patients

Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?

EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations

FP14.03 Diagnostic Accuracy in Central Pulmonary Carcinoid tumors is Dependent of Biopsy Size

Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors

Association of tumor and stroma PD-1, PD-L1, CD3, CD4 and CD8 expression with response to nivolumab treatment in NSCLC patients

P66.04 A Multimodal Biomarker Predicts Dissemination of Bronchial Carcinoid

Aktive Filter

Suchergebnisse filtern